B lymphocytes differentially use the Rel and nuclear factor κB1 (NF- κB1) transcription factors to regulate cell cycle progression and apoptosis in quiescent and mitogen-activated cells

Journal of Experimental Medicine

Volumn 187, Issue 5, 1998, Pages 663-674

  Grumont, Raelene J ^a   Rourke, Ian J ^a   O'Reilly, Lorraine A ^a   Strasser, Andreas ^a   Miyake, Kensuke ^b   Sha, William ^c   Gerondakis, Steve ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b SAGA UNIVERSITY   (Japan)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; IMMUNE RESPONSE; LYMPHOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSCRIPTION INITIATION; TRANSGENE;

ANIMALS; APOPTOSIS; B-LYMPHOCYTES; CELL CYCLE; CELL DIFFERENTIATION; CELL SIZE; CELLS, CULTURED; CYTOKINES; G1 PHASE; HEMATOPOIESIS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MITOGENS; NF-KAPPA B; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-REL; TRANSCRIPTION FACTORS;

EID: 0032473405     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.5.663     Document Type: Article

References (54)

1. Cory, S. 1995. Regulation of lymphocyte survival by the bcl-2 gene family. Annu. Rev. Immunol. 13:513-543.
2. Clevers, H.C., and R. Grosschedl. 1996. Transcriptional control of lymphoid development: lessons from gene targeting. Immunol. Today. 17:336-343.
3. Kontgen, F., R.J. Grumont, A. Strasser, D. Metcalf, R. Li, D. Tarlinton, and S. Gerondakis. 1995. Mice lacking the c-Rel protooncogene exhibit defects in lymphocyte proliferation, humoral immunity and interleukin-2 expression. Genes Dev. 9:1965-1977.
4. Sha, W.C., H.-C. Liou, E.I. Toumanen, and D. Baltimore. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in the immune system. Cell. 80:321-330.
5. Snapper, C.M., P. Zelazowski, F.R. Rosas, M.R. Kehry, M. Tian, D. Baltimore, and W.C. Sha. 1996. B cells from p50/ NF-κB knockout mice have selective defects in proliferation, differentiation, germ-line CH transcription, and Ig class switching. J. Immunol. 156:183-191.
6. Grilli, M., J.-S. Chiu, and M.J. Lenardo. 1993. NF-κB and Rel: participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1-62.
7. Baeuerle, P.A., and T. Henkel. 1994. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol. 12: 141-179.
8. Baldwin, A.S. 1995. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-681.
9. Nolan, G.P., and D. Baltimore. 1992. The inhibitory ankyrin and activator Rel proteins. Curr. Opin. Genet. Dev. 2:211-220.
10. Finco, T.S., and A.S. Baldwin. 1995. Mechanistic aspects of NF-κB regulation: the emerging role of phosphorylation and proteolysis. Immunity. 3:263-272.
11. Verma, I.M., J.K. Stevenson, E.M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
12. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Seibenlist. 1995. Control of IκBα: proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1485-1491.
13. DiDonato, J., F. Mercurio, C. Rosette, J. Wu-Li, H. Suyang, S. Ghosh, and M. Karin. 1996. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol. 16:1295-1304.
14. Chen, Z., J. Hagler, V.J. Palombella, F. Melandri, D. Scherer, D. Ballard, and T. Maniatis. 1995. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteosome pathway. Genes Dev. 9:1586-1597.
15. Didonato, J.A., F. Mercurio, and M. Karin. 1995. Phosphorylation of I kappa B alpha preceeds but is sufficient for its dissociation from NF-kappa B. Mol. Cell. Biol. 15:1302-1311.
16. Burkly, L., C. Hession, L. Ogata, C. Reilly, L.A. Marconi, D. Olsen, R. Tizard, R. Cate, and D. Lo. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature. 373:531-536.
17. Weih, F., D. Carrasco, S.K. Durham, D.S. Barton, C.A. Rizzo, R-P. Ryseck, S.A. Lira, and R. Bravo. 1995. Multiorgan inflammation and hemopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/ Rel family. Cell. 80:331-340.
18. Beg, A.A., W.C. Sha, R. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the relA component of NF-κB. Nature. 376: 167-170.
19. Gerondakis, S., A. Strasser, D. Metcalf, G. Grigoriadis, J.-Y.P. Scheerlink, and R.J. Grumont. 1996. Rel deficient T cells exhibit defects in the production of interleukin-3 and granulocyte-macrophage colony stimulating factor. Proc. Natl. Acad. Sci. USA. 93:3405-3409.
20. Grigoriadis, G., Y. Zhan, R.J. Grumont, D. Metcalf, E. Handman, C. Cheers, and S. Gerondakis. 1996. The Rel subunit of NF-κB-like transcription factors is a positive and negative regulator of macrophage gene expression: distinct roles for Rel in different macrophage populations. EMBO (Eur. Mol. Biol. Organ.) J. 15:7099-7107.
21. Beg, A.A., and D. Baltimore. 1996. An essential role for NF-κB in preventing TNF-α induced cell death. Science. 274: 782-784.
22. VanAntwerp, D.J., S. Martin, T. Kafri, D.R. Green, and I.M. Verma. 1996. Supression of TNF-α induced-apoptosis by NF-κB. Science. 274:787-789.
23. Wang, C.-Y., M.W. Mayo, and A.S. Baldwin. 1996. TNF-α and cancer therapy-induced apoptosis: potentiation by inhibition of NF-κB. Science. 274:784-787.
24. Lui, Z.-G., H. Hsu, D.V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell. 87:565-576.
25. Abbadie, C., N. Kabrun, F. Bouali, J. Smardova, D. Stehelin, B. Bandenbunder, and P.J. Enrietto. 1993. High levels of c-rel expression are associated with programmed cell death in the developing avian embryo and in bone marrow cells in vitro. Cell. 75:899-912.
26. Strasser, A., A.W. Harris, and S. Cory. 1991. Bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell. 67:889-899.
27. Miyake, K., Y. Yamashita, Y. Hitoshi, K. Takatsu, and M. Kimoto. 1994. Murine B cell proliferation and protection from apoptosis with an antibody against a 105-kD molecule: unresponsiveness of X-linked immunodeficient B cells. J. Exp. Med. 180:1217-1224.
28. Fulcher, D.A., and A. Basten. 1994. Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med. 179:125-134.
29. Taylor, I.W. 1980. A rapid single step staining technique for DNA analysis by flow microfluorimetry. J. Histochem. Cytochem. 28:1021-1024.
30. Crissman, H.A., Z. Darzynkiewicz, J.A. Steinkamp, and R.A. Tobey. 1990. Simultaneous fluorescent labeling of DNA, RNA and protein. Methods Cell Biol. 33:305-314.
31. Grumont, R.J., and S. Gerondakis. 1990. Murine c-rel transcription is rapidly induced in T cells and fibroblasts by mitogenic agents and the phorbol ester 12-O-tetradecanoylphorbol-13-acetate. Cell Growth Differ. 1:345-350.
32. Bernard, O., S. Cory, S. Gerondakis, E. Webb, and J.M. Adams. 1983. Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO (Eur. Mol. Biol. Organ.) J. 2:2375-2383.
33. Piechazyk, M., J.H. Blanchard, L. Martin, C. Dani, F. Panabieres, S. El Sabrouty, and P. Jeanteur. 1984. Post-transcriptional regulation of glyceraldehyde-3-phosphate-dehydrogenase gene expression in rat tissue. Nucleic Acids Res. 12:6951-6963.
34. McHeyzer-Williams, M.G. 1989. Combinations of interleukins 2, 4 and 5 regulate the secretion of murine immunoglobulin isotypes. Eur. J. Immunol. 19:2025-2030.
35. Gold, M.R., and A.L. DeFranco. 1994. Biochemistry of B lymphocyte activation. Adv. Immunol. 55:221-295.
36. Wetzel, G.D., S.L. Swain, R.W. Dutton, and J.R. Kettman. 1984. Evidence for two distinct activation states available in B lymphocytes. J. Immunol. 133:2327-2332.
37. DeFranco, A.L., E.S. Raveche, and W.E. Paul. 1985. Separate control of B lymphocyte early activation and proliferation in response to anti-IgM antibodies. J. Immunol. 135:87-94.
38. Klaus, G., C.M. Hawrylowicz, and C.J. Carter. 1985. Activation and proliferation signals in mouse B cells. VI. Anti-Ig antibodies induce dose-dependent cell cycle progression in B cells. Immunology. 55:411-418.
39. Strasser, A., A.W. Harris, D. Vaux, E. Webb, S. Bath, J.M. Adams, and S. Cory. 1990. Abnormalities of the immune system induced by dysregulated bcl-2 expression in transgenic mice. Curr. Top. Microbiol. Immunol. 166:175-181.
40. Schauer, S.L., Z. Wang, G.E. Sonenshein, and T.L. Rothstein. 1996. Maintainance of nuclear factor-κB/Rel and c-myc expression during CD40 ligand rescue of WEHI231 early B cells from receptor-mediated apoptosis through modulation of IκB proteins. J. Immunol. 157:81-86.
41. Wu, M., H. Lee, R. Bellas, S. Schauer, M. Arsura, D. Katz, M.J. FitzGerald, T.L. Rothstein, D.H. Sherr, and G.E. Sonenshein. 1996. Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO (Eur. Mol. Biol. Organ.) J. 15:4682-4690.
42. Kelly, K., B.H. Cochran, C. Stiles, and P. Leder. 1983. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet derived growth factor. Cell. 35:603-610.
43. Parker, D.C. 1993. T cell dependent B cell activation. Annu. Rev. Immunol. 11:331-360.
44. Clarke, E.A., and J.A. Ledbetter. 1994. How B and T cells talk to each other. Nature. 367:425-428.
45. Grumont, R.J., and S. Gerondakis. 1994. The subunit composition of NF-κB complexes changes during B-cell development. Cell Growth Differ. 5:1321-1331.
46. Liou, H.-C., W.C. Sha, M.L. Scott, and D. Baltimore. 1994. Sequential induction of NF-κB/Rel family proteins during B cell terminal differentiation. Mol. Cell. Biol. 14:5349-5359.
47. Miyamoto, S., M.J. Schmitt, and I.M. Verma. 1994. Qualitative changes in the subunit composition of κB-binding complexes during murine B-cell differentiation. Proc. Natl. Acad. Sci. USA. 91:5056-5060.
48. Doi, T.S., T. Takahashi, O. Taguchi, A. Takachika, and Y. Obata. 1997. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J. Exp. Med. 185:953-961.
49. Perkins, N.D., L.K. Felzien, J.C. Betts, K. Leung, D. Beech, and G.J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science. 275:523-527.
50. Baldwin, A.S., J.C. Azizkhan, D.E. Jensen, A.A. Beg, and L.R. Coodly. 1991. Induction of NF-κB DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts. Mol. Cell. Biol. 11:4943-4951.
51. Jung, M., Y. Zhang, S. Lee, A. Dritschilo. 1995. Correction of radiation sensitivity in ataxia telengiectasia by a truncated IκB-α. Science. 268:1619-1621.
52. Grimm, S., M. Bauer, P.A. Baeuerle, and K. Schulze-Osthoff. 1996. Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J. Cell. Biol. 134:13-23.
53. Evan, G.I., A.H. Wyllie, C.S. Gilbert, T.D. Littlewood, H. Land, M. Brooks, C.M. Waters, L.Z. Penn, and D.C. Hancock. 1991. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 69:119-128.
54. Chu, Z.-L., T.A. McKinsey, L. Liu, J.J. Gentry, M.H. Malim, and D.W. Ballard. 1997. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control. Proc. Natl. Acad. Sci. USA. 94:10057-10062.